• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Innovation in Nutraceuticals: Dose Forms and Application Science Help Meet Consumer Demand

    Researchers Develop New Global Estimate of Medicinal Plant Species and Conservation Status

    All Eyes on Vision Health

    Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health

    Vitamin D: A Fixture of Supplementation and Fortification
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Glossary
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Tocotrienols May Have Protective Effect on Liver in NAFLD Patients

    Indian Gooseberry Extract Shown to Offer Blood Sugar Management Benefits

    ADM Expands Production to Meet Demand for Probiotics

    Wiley’s Finest Debuts Peak DHA Featuring 600 mg of DHA and 300 mg of EPA

    FDA to Allow Qualified CVD Risk Reduction Claim for Cocoa Flavanols in High Flavanol Cocoa Powder
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Tocotrienols May Have Protective Effect on Liver in NAFLD Patients

    Indian Gooseberry Extract Shown to Offer Blood Sugar Management Benefits

    Rhodiola Added to CITES List of Protected Species

    ADM Expands Production to Meet Demand for Probiotics

    Wiley’s Finest Debuts Peak DHA Featuring 600 mg of DHA and 300 mg of EPA
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    ICYMI: Top Content from January 2023 on NutraceuticalsWorld.com

    Tocotrienols May Have Protective Effect on Liver in NAFLD Patients

    Indian Gooseberry Extract Shown to Offer Blood Sugar Management Benefits

    Rhodiola Added to CITES List of Protected Species

    FDA to Allow Qualified CVD Risk Reduction Claim for Cocoa Flavanols in High Flavanol Cocoa Powder
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Indian Gooseberry Extract Shown to Offer Blood Sugar Management Benefits

    Wiley’s Finest Debuts Peak DHA Featuring 600 mg of DHA and 300 mg of EPA

    FDA to Allow Qualified CVD Risk Reduction Claim for Cocoa Flavanols in High Flavanol Cocoa Powder

    Overall Health, Immune Support, and Mental Wellness Drive VMS Usage

    Balchem Discusses Growth Trajectory for Portfolio of Specialty Ingredients in Key Markets
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    BGG Americas, Inc.

    Botanic Healthcare LLC

    Bioenergy Life Science, Inc. (BLS)

    Chenguang Biotech Group Co., Ltd.

    Xsto Solutions
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    BGG Americas, Inc.

    Botanic Healthcare LLC

    Bioenergy Life Science, Inc. (BLS)

    Chenguang Biotech Group Co., Ltd.

    Xsto Solutions
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • Infographics
    • eBook
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Columns

    CBD Regulatory Status Update: The Chaos Continues

    FDA already has the authority to create a legal pathway for cannabidiol. It just needs the will to implement it.

    CBD Regulatory Status Update: The Chaos Continues
    Related Content
    • Sunflower Hemp Co
    • Clearing Up Chaos in the Modern Nutraceuticals Market
    • The CBD Craze: Still Only the Beginning
    • Cannovia: Clearing Up CBD Market Confusion
    • Area Code 420 Has Arrived
    By Todd Harrison, Venable09.09.19
    The FDA continues to struggle with how to regulate CBD and hemp extracts. What was thought by some to be a pivotal meeting on the issue on May 31 only served to create further chaos in the marketplace.

    Major retailers simply did not get the assurances they wanted from FDA that moving forward with CBD-containing dietary supplement or food products was worth the venture. Similarly, the credit-card processors did not get the assurance they desired. Consumers still seem confused as to what exactly is hemp, marijuana, CBD, etc. The pharmaceutical industry repeated its concerns that the integrity of the drug approval process must be protected—a position reiterated by Congress in a letter to FDA.

    Industry offered no real solutions, only platitudes; but then again why should it offer anything to FDA. Indeed, CBD/hemp food and dietary supplement products have exploded even though FDA has consistently stated the products are not lawfully marketed because of the presence of CBD. FDA continues to search for a way out of its predicament, urging stakeholders to provide the necessary safety information confirming CBD is safe to be consumed on a daily basis, and how to make it available to the general public through the rulemaking process.

    In the meantime, the states have started to make their opinions known, whether through policy statements or laws. Texas, understanding the economic boom that hemp and CBD could have to its economy, passed one of the most liberal laws regarding this issue. Yet, New York state and New York City have made it clear that CBD will not be allowed in food until FDA states that it’s OK.

    Massachusetts has similarly come down hard on CBD-containing products. Yet, this freight train appears to have left the station, and nobody seems to understand how to tame it. 

    The Pathway Exists Already
    I was originally highly skeptical about the CBD market. I was certain that like all other ingredients it would peak then die. My own opinion on the legality of CBD and hemp products has also evolved. While I believe there’s still a significant amount of spurious legal arguments—including the claim that Phase I and II clinical trials do no constitute the institution of significant clinical trials—I believe there is a path forward for FDA and industry.

    First, however, it requires FDA to abandon its rather obtuse positon that the preclusion provisions found in Sections 201(ff)(3) and 301(ll)(3) of the Federal Food, Drug and Cosmetic Act necessarily exclude the use of CBD-containing hemp extracts from being marketed as either food or dietary ingredients. This narrow thinking has hamstrung the agency from actually moving forward with a more reasoned approach.

    Indeed, if FDA would follow its own position as to what constitutes the article that is a drug or the drug itself, the agency could simply announce the pathway forward, rather than inventing a convoluted regulatory process that would likely take years to implement.

    The pathways, both on the dietary supplement and food sides, already exist. But first let’s deal with that pesky issue as to what constitutes the “article” or “drug” (collectively, “the drug”) that is either the subject of substantial clinical investigation (and for dietary supplements an Investigational New Drug) or FDA drug approval prior to introduction into the food supply or as part of a dietary ingredient.

    More specifically, FDA itself has acknowledged that Epidiolex is not a botanical. Moreover, FDA acknowledged that a drug is necessarily defined by its intended use. In this regard, the agency defined a “drug” studied under IND to have very specific attributes related to its active ingredient, pharmacological class, structural formula, formulation of the dosage form to be used, and route of administration (see 21 C.F.R. 312.23).

    In this regard, simply comparing the drug that has been approved by FDA, Epidiolex, and the drug that is still under clinical investigation, Sativex, it becomes abundantly clear that a broad spectrum hemp extract is not precluded under Section 201(ff)(3) or 301(ll)(3), as it does not in any manner resemble these two drugs. Indeed, one only has to do a side by side comparison of the three ingredients to conclude that each is uniquely different and that hemp extracts that contain low levels of CBD simply do not resemble either of these drugs.

    To Congress, I would simply state that the availability of fish oil certainly did not stop pharmaceutical companies from investigating its use as a drug. At best, this argument that CBD-containing hemp extracts will somehow impact drug development is simply without merit. If there is economic and medical value to get a hemp extract that contains CBD approved, the pharmaceutical industry will pursue it, just as it did fish oil.

    So, where does that leave us today? There are several processes that can be utilized to market CBD and hemp extracts. On the dietary supplement side, the filing of a New Dietary Ingredient Notification (NDIN) with FDA is one pathway. Another is to file a petition with FDA requesting an order that the product may be marketed as a dietary ingredient after a showing that it has reasonable expectation of safety. On the food side, the Generally Recognized As Safe (GRAS) notification process exists as well as the food additive petition; both require showing that the ingredients are safe.

    The Box is Open
    In other words, there is ample regulatory processes already in place which do not require potentially years of regulatory wrangling that will simply slow the process. FDA must evolve its thinking and stop hiding behind preclusion and the concern that Pandora’s box will be open. Here’s a news flash: it is already opened and the flood gates have been let loose. It’s time to think outside the proverbial lock box that regulatory agencies prefer and get moving on this one. It is time for this process to move forward rather than stagnate, which keeps a cloud over the food and dietary supplement products that contain CBD and only serves to make plaintiff attorneys wealthy in the end. 

    No, just because the public demands an ingredient, doesn’t mean it should be legalized. However, if the ingredient can be shown to be GRAS for use in food and a reasonable likelihood of safety in dietary supplements, FDA must allow the ingredient to be marketed, and FDA already has the process to do so in place.


    Todd Harrison
    Venable

    Todd Harrison is partner with Venable, which is located in Washington, D.C. He advises food and drug companies on a variety of FDA and FTC matters, with an emphasis on dietary supplement, functional food, biotech, legislative, adulteration, labeling and advertising issues. He can be reached at 575 7th St. NW, Washington, D.C. 20004, Tel: 202-344-4724; E-mail: taharrison@venable.com.
    Related Searches
    • labeling
    • Extracts
    • ftc
    • Botanical
    Related Knowledge Center
    • Herbs & Botanicals
    • Quality & Safety
    • Regulations
    • Dietary Supplements
    Suggested For You
    Sunflower Hemp Co Sunflower Hemp Co
    Clearing Up Chaos in the Modern Nutraceuticals Market Clearing Up Chaos in the Modern Nutraceuticals Market
    The CBD Craze: Still Only the Beginning The CBD Craze: Still Only the Beginning
    Cannovia: Clearing Up CBD Market Confusion Cannovia: Clearing Up CBD Market Confusion
    Area Code 420 Has Arrived Area Code 420 Has Arrived
    Charlotte’s Web Introduces Hemp Extract-Infused Gummies Charlotte’s Web Introduces Hemp Extract-Infused Gummies
    Levagen PEA: A Legal Answer to CBD’s Issues Levagen PEA: A Legal Answer to CBD’s Issues
    DSHEA Discussion: Assessing Standards for Scientific Evidence DSHEA Discussion: Assessing Standards for Scientific Evidence
    Move Over Mainstream, Healthy Foods Are Here to Stay Move Over Mainstream, Healthy Foods Are Here to Stay
    Gencor Partners with Cannabis Researcher to Promote CBD Alternatives Gencor Partners with Cannabis Researcher to Promote CBD Alternatives
    OptiPEA Offers an Alternative to ‘Problem Child’ CBD OptiPEA Offers an Alternative to ‘Problem Child’ CBD
    ‘Can I Get Liability Insurance for My ‘Illegal’ CBD Products? ‘Can I Get Liability Insurance for My ‘Illegal’ CBD Products?
    Pet Supplements: A Regulatory Briefing Pet Supplements: A Regulatory Briefing
    GW Pharmaceuticals Receives ABC Tyler Award for Phytomedicinal Research GW Pharmaceuticals Receives ABC Tyler Award for Phytomedicinal Research

    Related Buyers Guide Companies

    • Sunflower Hemp Co

      ...
      Colby Terip, Owner 09.15.21

    • Dietary Supplements | Healthcare Trends
      Clearing Up Chaos in the Modern Nutraceuticals Market

      Clearing Up Chaos in the Modern Nutraceuticals Market

      Demand for novel, holistic wellness solutions has pushed the industry in new territory.
      By Sean Moloughney, Editor 09.09.19

    • Consumer Trends | Healthcare Trends | Herbs & Botanicals | Mood Health & Sleep | Natural/Organic | Research
      The CBD Craze: Still Only the Beginning

      The CBD Craze: Still Only the Beginning

      Consumers are craving hemp products, and brands are set to deliver despite regulatory uncertainty.
      By Sean Moloughney, Editor, Nutraceuticals World 09.03.19


    • Herbs & Botanicals | Quality & Safety
      Cannovia: Clearing Up CBD Market Confusion

      Cannovia: Clearing Up CBD Market Confusion

      CEO Brian Baum discusses the future of CBD innovation and product development.
      By Sheldon Baker 08.30.19

    • Herbs & Botanicals
      Area Code 420 Has Arrived

      Area Code 420 Has Arrived

      Introducing Nutraceuticals World’s new Q&A column featuring entrepreneurs in the CBD, cannabis, hemp, and cannabinoid markets.
      By Sheldon Baker, Baker Dillon Group LLC 07.03.19

    Loading, Please Wait..
    Trending
    • Vitamin D Supplementation Reduces Risk Of Dynapenia
    • Study Examines Vitamin K2 Content In Cheese
    • Shiitake Mushroom Extract Appears Helpful In HPV Infections
    Breaking News
    • Tocotrienols May Have Protective Effect on Liver in NAFLD Patients
    • Indian Gooseberry Extract Shown to Offer Blood Sugar Management Benefits
    • ADM Expands Production to Meet Demand for Probiotics
    • Wiley’s Finest Debuts Peak DHA Featuring 600 mg of DHA and 300 mg of EPA
    • FDA to Allow Qualified CVD Risk Reduction Claim for Cocoa Flavanols in High Flavanol Cocoa Powder
    View Breaking News >
    CURRENT ISSUE

    Jan/Feb 2023

    • Healthy, Clean Label Snacks and Nutrition Bars Help Fill Nutrient Gap Cleaved By Modern Lifestyles
    • Magnesium: An Essential Mineral with Many Forms and Functions
    • Vitamin D: A Fixture of Supplementation and Fortification
    • Health Benefits of Vitamin K: A Contemporary Cornerstone of Heart and Bone Health
    • All Eyes on Vision Health
    • Researchers Develop New Global Estimate of Medicinal Plant Species and Conservation Status
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Tocotrienols May Have Protective Effect on Liver in NAFLD Patients
    Indian Gooseberry Extract Shown to Offer Blood Sugar Management Benefits
    ADM Expands Production to Meet Demand for Probiotics
    Coatings World

    Latest Breaking News From Coatings World

    AkzoNobel Reports Revenue Growth in 2022
    Orion Engineered Carbons Announces New Distribution Partnerships
    Personnel Changes at BASF
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    PDC Unveils New Brand Identity
    MD&M West News: Teamvantage Launches New Parent Company
    BD Receives EUA from FDA for COVID-19, Influenza A/B, RSV Combination Test
    Contract Pharma

    Latest Breaking News From Contract Pharma

    KORSCH Acquires MEDELPHARM to Strengthen R&D Product Line
    SRI Names Kathlynn Brown Biosciences Division President
    Battelle, AmplifyBio, Andelyn Biosciences Win Research Contract
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Kiss Colors & Care Taps Rapper JT as Brand Partner
    Revolution Beauty Expands into Walmart in the U.S.
    Macro-Environmental Factors Impacting the Packaging Industry
    Happi

    Latest Breaking News From Happi

    Perfect Corp. Receives MLPS 2.0-Compliant Status to Help Beauty and Fashion Brands Meet China's National Cybersecurity Standards
    Ocean Conservation Managers Convene for Fifth International Marine Protected Area Congress, Receives Private Sector Support From Mary Kay Inc.
    Mintel Reveals Macro-Environmental Factors Impacting Household and Personal Care Packaging
    Ink World

    Latest Breaking News From Ink World

    Orion Carbons Announces New Distribution Partnerships
    DuPont Reports 4Q, Full Year 2022 Results
    Graphic Packaging Reports Strong 4Q, Full Year 2022 Results
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    'Build Back the Wisconsin Paper Industry' event announced
    Magic Johnson to keynote Dscoop Edge St. Louis World Expo
    Norway's Digital Etikett grows with HP Indigo
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Edgewell’s Sales Increase
    Mitsui Chemicals, Asahi Kasei Combine Nonwovens Businesses
    Hospeco Offers TaskBrand Prep-Paint-Finish Wiping System
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    OssDsign Launches New Product for Additional Surgical Procedures
    OSSIO Introduces Non-Permanent Compression Staple
    Dennis Jones Joins Intelivation Technologies as Manufacturing VP
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Identiv Expands NFC and HF Solutions Portfolio
    HID Acquires GuardRFID to Expand Healthcare Offering
    DuPont Reports Fourth Quarter, Full Year 2022 Results

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login